1Overgaard K, Sereghy T, Pederson H, et al. Effect of delayed thrombel- ysis with rt - PA in a rat embolic stroke mode[J], l Cereb Blood Flow Metab, 1994,14:472.
2Gross CE, Raymond S J, Howard DB, et al. Delayed tissue plasminogen activator therapy in a rabbit model of thrombeebolic stroke[ J]. Neuro- surgery, 1995,36 : 1172.
3Donnan GA, Davis SM, Chambers BR,et al. Streptokinase for acut eis- chemic stroke with relationship to time of administration [ J ], JAldA, 1996.27634.961 - 966.
5Graham GD. Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical ractice: A Meta - Analysis of Safety Data [ J ]. Stroke, 2003,34(12) :2847 -2850.
10Bhatia R, Hill MD, Shobha N ,et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ische- mic stroke[ J ]. Stroke,2010,41 (10) :2254 - 2258.
5Graham G D. Tissue plasminogen activator for acute is-chemic stroke in clinical ractice:A meta-analysis of safetydata[J]. Stroke,2003,34(12):2847-2850.
6Patel R A,White C J. Acute ischemic stroke treatment:state of the art[J]. Vase Med,2011,16(1):19-28.
7Bluhmki E,Chamorro A, Davalos A,et al. Stroke treat-ment with alteplase given 3. 0?4. 5 h after onset ofacuteischaemic stroke (ECASS 1 ):additional outcomesandsubgroup analysis of a randomised controlled trial [J].Lancet Eurol,2009,8(12):1095-1102.
8Lees K R, Bluhmki E, Von Kummer R, et al. Time totreatment with intravenous alteplase and outcome instroke:an updated pooled analysis of ECASS, ATLAN-TIS, NINDS and EPITHET trials[J]. Lancet,2010,375:1695-1703.
